Approved 9/2019. Criteria for use: for intra-abdominal infections from ESBL-producing bacteria with known sensitivity to eravacycline. Not for pseudomonas sp. 

• Micromedex Drug Information
• Micromedex Care Notes
• Drugs@FDA
• FDA Daily Med Package Inserts